Activity of Meropenem with and without Ciprofloxacin and Colistin against Pseudomonas aeruginosa and Acinetobacter baumannii

@article{Pankuch2007ActivityOM,
  title={Activity of Meropenem with and without Ciprofloxacin and Colistin against Pseudomonas aeruginosa and Acinetobacter baumannii},
  author={G. Pankuch and G. Lin and H. Seifert and P. Appelbaum},
  journal={Antimicrobial Agents and Chemotherapy},
  year={2007},
  volume={52},
  pages={333 - 336}
}
ABSTRACT Time-kill synergy studies showed that at 24 h, subinhibitory meropenem and ciprofloxacin concentrations of 0.06 to 128 and 0.03 to 32 μg/ml, respectively, showed synergy against 34/51 Pseudomonas aeruginosa strains; subinhibitory concentrations of meropenem (0.06 to 8 μg/ml) and colistin (0.12 to 1 μg/ml) showed synergy against 13 isolates. Subinhibitory meropenem and ciprofloxacin concentrations of 0.25 to 2 and 0.12 to 16 μg/ml, respectively, showed synergy against 18/52… Expand

Figures and Topics from this paper

Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.
In vitro efficacy of various antibiotic combinations against Pseudomonas aeruginosa isolates
Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.
The detection of synergy between meropenem and polymyxin B against meropenem-resistant Acinetobacter baumannii using Etest and time-kill assay.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 39 REFERENCES
A comparative study of the in vitro activity of meropenem and representatives of the major classes of broad-spectrum antibiotics.
  • J. Greenhalgh, J. R. Edwards
  • Biology, Medicine
  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 1997
...
1
2
3
4
...